Introduction Alzheimer’s disease is a major health concern worldwide as it is one of the main conditions underlying dementia. Although various treatments have been developed to manage the disease,…
One of the many benefits of being a member of the British Pharmacological Society is that it gives you the opportunity to apply for our prizes and awards, which help to support members throughout…
Science has never played a more central role in people’s lives than it has during the COVID-19 pandemic. The rapid progression of knowledge and the record-breaking speed of vaccine development…
Rosemary Gaw, University of Strathclyde, was a runner up from our 2021 annual writing competition for early career pharmacologists. For each writing competition, we look for exceptionally written…
Antibodies are the extraordinary proteins that help to protect us from a wide range of infections and have been exploited for their specificity to treat a wide range of diseases.
For many years, the British Pharmacological Society has supported Open Access (OA) publishing in its journals. Our members and our authors have a range of needs, and a…
Issues surrounding reproducibility and research integrity have been identified from as early as 2005. In 2017, this select committee held an inquiry into research integrity (you can…
Today (Friday 19 November 2021) the British Pharmacological Society and the British Society for Antimicrobial Chemotherapy (BSAC) have jointly launched a new eLearning resource – the BSAC…
Between February and May 2020, UKRI conducted a public consultation on their future Open Access policy, as part of the UKRI Open Access Review. UKRI’s intention is to create a “a…
